Back

Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial

European Heart Journal

6 October 2021
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure OTHER

Contributors

Cecilia Linde
Cecilia Linde

Author

Karolinska Institute Stockholm , Sweden

You may be interested in
thumbnail
Congress Session
Rhythm control in patients with structural heart disease
1 April 2025
thumbnail
Congress Presentation
Innovation in pacing therapies: where technology meets physiology
1 September 2025
thumbnail
Congress Presentation
Cardiac resynchronization therapy in permanent atrial fibrillation
22 May 2023
thumbnail
Webinar
New 2021 HF guidelines - what is new for device therapies and how to optimally combine new HF drugs with ICD-CRTDs
16 February 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources